Susquehanna International Group
LABD icon

Susquehanna International Group’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Susquehanna International Group’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$370K Sell
22,711
-21,037
-48% -$398K ﹤0.01% 10403
2025
Q4 		$921K Buy
43,748
+12,668
+41% +$344K ﹤0.01% 7372
2025
Q3 		$1.26M Buy
31,080
+25,678
+475% +$1.49M ﹤0.01% 6791
2025
Q2 		$404K Sell
5,402
-32,257
-86% -$2.85M ﹤0.01% 9653
2025
Q1 		$3.55M Sell
37,659
-13,453
-26% -$985K ﹤0.01% 4318
2024
Q4 		$3.71M Buy
51,112
+15,592
+44% +$954K ﹤0.01% 4083
2024
Q3 		$2.07M Sell
35,520
-19,719
-36% -$1.2M ﹤0.01% 5201
2024
Q2 		$4.05M Buy
55,239
+12,203
+28% +$1.03M ﹤0.01% 3795
2024
Q1 		$3.14M Buy
43,036
+29,566
+219% +$2.47M ﹤0.01% 4441
2023
Q4 		$1.31M Sell
13,470
-1,201
-8% -$234K ﹤0.01% 6332
2023
Q3 		$3.02M Sell
14,671
-31,711
-68% -$5.15M ﹤0.01% 4374
2023
Q2 		$6.67M Buy
46,382
+38,538
+491% +$5.76M ﹤0.01% 3074
2023
Q1 		$1.62M Buy
7,844
+931
+13% +$158K ﹤0.01% 5619
2022
Q4 		$1.19M Sell
6,913
-49,167
-88% -$10.1M ﹤0.01% 5798
2022
Q3 		$13.4M Buy
56,080
+38,890
+226% +$9.03M ﹤0.01% 1822
2022
Q2 		$6.69M Buy
17,190
+10,964
+176% +$5.5M ﹤0.01% 2748
2022
Q1 		$2.18M Sell
6,226
-5,552
-47% -$2.18M ﹤0.01% 5280
2021
Q4 		$3.03M Buy
11,778
+4,768
+68% +$1.1M ﹤0.01% 4622
2021
Q3 		$1.49M Buy
7,010
+1,967
+39% +$418K ﹤0.01% 6497
2021
Q2 		$973K Sell
5,043
-6,734
-57% -$1.51M ﹤0.01% 7853
2021
Q1 		$2.56M Sell
11,777
-15,724
-57% -$3.05M ﹤0.01% 5324
2020
Q4 		$6.95M Buy
27,501
+20,503
+293% +$7.82M ﹤0.01% 2943
2020
Q3 		$4.18M Buy
6,998
+5,833
+501% +$3.76M ﹤0.01% 3306
2020
Q2 		$809K Buy
+1,165
New +$1.46M ﹤0.01% 6369
2020
Q1 		– Sell
-444
Closed -$1.27M – 10594
2019
Q4 		$1.1M Buy
444
+173
+64% +$614K ﹤0.01% 5349
2019
Q3 		$1.37M Buy
271
+108
+66% +$445K ﹤0.01% 5020
2019
Q2 		$587K Sell
163
-226
-58% -$952K ﹤0.01% 6941
2019
Q1 		$1.43M Buy
389
+252
+184% +$1.22M ﹤0.01% 4315
2018
Q4 		$1.17M Sell
137
-20
-13% -$147K ﹤0.01% 4381
2018
Q3 		$766K Sell
157
-527
-77% -$2.54M ﹤0.01% 5770
2018
Q2 		$3.54M Buy
684
+403
+143% +$2.44M ﹤0.01% 3160
2018
Q1 		$2.05M Buy
281
+143
+104% +$994K ﹤0.01% 3876
2017
Q4 		$1.27M Buy
138
+131
+1,871% +$1.3M ﹤0.01% 4753
2017
Q3 		$67K Sell
7
-110
-94% -$1.33M ﹤0.01% 8471
2017
Q2 		$1.61M Buy
117
+54
+86% +$1.04M ﹤0.01% 4305
2017
Q1 		$1.31M Buy
63
+28
+80% +$692K ﹤0.01% 4557
2016
Q4 		$1.32M Buy
+35
New +$1.35M ﹤0.01% 4941
2015
Q4 		– Sell
-18
Closed -$1.38M – 9701
2015
Q3 		$2.03M Buy
+18
New +$1.27M ﹤0.01% 4257

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Susquehanna International Group's LABD Position: Q1 2026 in Review

Susquehanna International Group reduced its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 48% in Q1 2026, selling an estimated $398K and leaving 22,711 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #10403.

Susquehanna International Group first reported a position in LABD in Q3 2015 and has held it in 38 quarters since. The position peaked at $13.4M in Q3 2022. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • Susquehanna International Group held 22,711 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $370K as of Q1 2026.
  • Susquehanna International Group sold 21,037 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $398K.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10403 holding.
  • Susquehanna International Group first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2015 and has held it in 38 quarters since.
  • Susquehanna International Group's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $13.4M in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.